Filippos Panteleimon Chatzipieris
5PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 28, 2026
Recent Advances in Dual COX/LOX Inhibitor Design (2020-2024): Establishing "The Rule of Four for Inflammation".Filippos Panteleimon Chatzipieris, Errikos Petsas, George Lambrinidis
|Jan 28, 2026
Structural and Computational Insights into the Angiotensin II Type 1 Receptor: Advances in Antagonist Design and Implications for Hypertension Therapy (2020-2024).Filippos Panteleimon Chatzipieris, Errikos Petsas, George Lambrinidis
|Dec 11, 2025
Structure-Based Design and In Silico Evaluation of a Lipophilic Cyclooctanoyl- Derivative as a Renin Inhibitor: Lessons from Withdrawn Aliskiren.Dimitrios Pavlos, Errikos Petsas, Filippos Panteleimon Chatzipieris
|Oct 15, 2025
Unraveling the Potential Pathogenic Role of Squalene Synthase (SQS) in Lung Cancer Using Enzyme Inhibitors as Molecular Tools.Theodora Katavati, Filippos P Chatzipieris, Christiana Magkrioti
|Jul 07, 2025
New Prospects in the Inhibition of Monoamine Oxidase‑B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer's Disease: A Review.Filippos Panteleimon Chatzipieris, Athanasios Kokkalis, Nikitas Georgiou
Pageof 1
Frequent Collaborators
4 joint publications
Errikos Petsas
2 joint publications
Thomas Mavromoustakos
2 joint publications
Christos T Chasapis
2 joint publications
George Lambrinidis
1 joint publications
Vassilis Aidinis
1 joint publications
Alexios N Matralis
1 joint publications
Angeliki P Kourounakis
1 joint publications
Nikitas Georgiou
1 joint publications
Georgios C Vougioukalakis
1 joint publications
Dimitrios Pavlos
